RenBio, Inc.
Biotechnology company · Long Island City, New York, United States
RenBio, Inc. is a biotechnology company headquartered in Long Island City, New York, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $5.3 million sold in a notice filed in 2024.
RenBio at a glance
What does RenBio do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $5.3 million sold (2024).
Frequently asked questions about RenBio
Where is RenBio headquartered?
RenBio, Inc. is headquartered in Long Island City, New York, United States.
What does RenBio do?
RenBio, Inc. is a biotechnology company.
When was RenBio founded?
The earliest incorporation on record for RenBio, Inc. is in 2020, according to public company registers.
Similar companies
- Health Rhythms Inc.Long Island City, New York, United States
- Qrons Inc.Long Island City, New York, United States
- Pyrojas IncLong Island City, New York, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences